Price $29.78 |
Market Cap
611.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.68
|
P/S
1.34
|
Dividend %
-
|
|
P/CF
185.5
|
P/FCF
48.8
|
Op. Cash Flow
29K
|
FCF
0.6
|
|
Op. Margin
1.00%
|
Net Margin
-3.30%
|
ROE
-4.20%
|
ROI
-0.90%
|
|
ROA
-2.90%
|
EPS Growth
-162.10%
|
Current Ratio
2.6
|
Debt/Equity
6.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generex Biotechnology Corporat (GNBT) | $0.05 | - | - | 7.6M | Strong Buy |
| Biomerica, Inc. (BMRA) | $3.96 | - | - | 48.8M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.50 | - | - | 68.5M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $63.86 | - | 3.50% | 138.77B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.22 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
